Rapport

Global Market Study: Human Rabies vaccines - December 2020

World Health Organization (WHO)

In addition to providing the most up-to date understanding of the current and future trajectory of global supply and demand of rabies vaccines for PrEP and PEP,8

this study identifies actions to help address the anticipated market dynamics and serves as an important resource for the implementation of the Zero by 30 strategy.

Auteurs

Langues

  • Anglais

Année de publication

2020

Éditeur

WHO

Type

Rapport

Catégories

  • Gestion de programme

Maladies

  • Rage

Mots-clés

  • MI4A
  • Planification, budgétisation et financement

Références sur le sujet

EPI-CORE-MI4A

TitreAuteurAnnéeTypeLangue
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportAnglais
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportAnglais
Global Market Study: HPV - April 2022World Health Organization (WHO)2020ReportAnglais
Global Market Study: Human Rabies vaccines - December 2020World Health Organization (WHO)2020ReportAnglais
Global Market Study: Measles-containing vaccines (MCV) - July 2020World Health Organization (WHO)2020ReportAnglais
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportAnglais
Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - June 2020World Health Organization (WHO)2020ReportAnglais
Global Market Study: Typhoid vaccines - 2020World Health Organization (WHO)2020ReportAnglais
MI4A Project OverviewWorld Health Organization (WHO)GuidanceAnglais
MI4A Vaccine Purchase DatabaseWorld Health Organization (WHO)DatasheetAnglais
Vaccine Price Report - 2017World Health Organization (WHO)2017ReportAnglais
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportAnglais

Ajouté par: Géraldine Nemrod

Ajouté le: 2021-01-30 08:04:26

Consultations: 1616

Liens

Ajouter une ressource